 |
|
|
|
|
|
|
|
|
|
|
 |
|
|||||||||
 |
 |
 |
|
|||||||
 |
 |
 |
 |
 |
 |
 |
|
|||
 |
 |
|
||||||||
NGN Capital
JAFCO NLV Partners Bio*One Capital NovaQuest Asahi Kasei Pharma Corporation InvestorsArtisan's investors each bring a unique skill set, global relationship network and strategic vision — all of which add complementary and synergistic value to the Company. By accessing and leveraging their resources, we seek to multiply the reach and value of our own team and resources.Bio*One Capital Bio*One Capital is a leading, dedicated biomedical sciences investment management company in Asia with a worldwide presence. With funds of over US$600 million, investments are focused on promising and innovative global biomedical companies where Bio*One Capital can play a value-adding role in bridging and supporting companies' growth strategies in Asia through their operations in Singapore. A part of the Singapore Economic Development Board, Bio*One Capital oversees a portfolio of over 60 companies in the U.S., Europe, Singapore and Asia. Visit www.biocapital.com.  |
||||||||||
 |
|
|||||||||